Specific Diagnostics: Johnny Ek
Specific Diagnostics has appointed Johnny Ek as its CFO. Since 2019, Ek has been the CFO of GenMark Diagnostics, which was recently acquired by Roche. Since 2013, Ek had been GenMark's controller and vice president of finance. Prior to joining GenMark, he was vice president and international controller at Affymetrix, now part of Thermo Fisher Scientific. He was also the controller at eBioscience prior to its sale to Affymetrix. Ek began his career as a certified public accountant at Ernst and Young, in the audit and advisory practice where he supported the initial public offerings of several San Diego-based life science firms. Specific Diagnostics is developing a direct-from-blood antimicrobial susceptibility diagnostic test.